Skip to main content

Advertisement

SpringerLink
Log in

What is the preclinical evidence on platelet rich plasma and intervertebral disc degeneration?

  • Review Article
  • Published:
European Spine Journal Aims and scope Submit manuscript

An Erratum to this article was published on 13 October 2015

Abstract

Purpose

Intervertebral disc degeneration is a common disease that usually starts from the third decade of life and it represents a significant cause of socio-economic problems. The accepted surgical treatment for disc degeneration is disc removal and vertebral fusion or, in selected cases, intervertebral disc arthroplasty. Several studies have demonstrated the ability of platelet rich plasma (PRP) to stimulate cell proliferation and extracellular matrix regeneration. However, literature results are still limited and more studies are required to clarify the role of PRP in the prevention or in the treatment of degenerative disc disease. The aim of this review is to summarize and critically analyze the current preclinical evidence about the use of PRP in intervertebral disc degeneration.

Methods

Literature search was performed through various combinations of the following keywords: Intervertebral Disc Degeneration, Platelet Rich Plasma, PRP, Intervertebral disc regeneration. Papers included in our review cover the period between 2006 and 2014. The PRISMA 2009 checklist was followed.

Results

At the end of the review process, 12 articles were included in our final manuscript, including 6 “in vitro” and 6 “in vivo” studies. All the included studies lead to positive preclinical results. No standardization of methodological analysis was observed.

Conclusion

It is not possible to draw definitive evidence about the use of PRP in IVD regeneration. We advise a proper standardization of the methodological analysis in order to compare the available data and achieve definitive results. This should be the cornerstone for future clinical applications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Habibi Z, Maleki F, Meybodi AT, Mahdavi A, Saberi H (2014) Lumbosacral sagittal alignment in association to intervertebral disc diseases. Asian Spine J. 8(6):813–819

    Article  PubMed Central  PubMed  Google Scholar 

  2. Roberts S, Evans H, Trivedi J, Menage J (2006) Histology and pathology of the human intervertebral disc. J Bone Joint Surg Am 88(Suppl 2):10–14

  3. Shankar H, JA, Scarlett, SE. Abram (2009) Anatomy and pathophysiology of intervertebral disc disease. Tech Reg Anesth Pain Manag 13:67–75

  4. Neroni M, Gazzeri R, Conforti G, Visocchi M (2014) State of art of recurrent lumbar disk herniation, interspinous and interlumbar fusions. J Neurosurg Sci 58(2 Suppl 1):45–48

    CAS  PubMed  Google Scholar 

  5. Migacz K, Chłopek J, Morawska-Chochół A, Ambroziak M (2014) Gradient composite materials for artificial intervertebral discs. Acta Bioeng Biomech 16(3):3–12

    PubMed  Google Scholar 

  6. Wang SZ, Rui YF, Lu J, Wang C (2014) Cell and molecular biology of intervertebral disc degeneration: current understanding and implications for potential therapeutic strategies. Cell Prolif 47(5):381–390

    Article  CAS  PubMed  Google Scholar 

  7. Sivan SS, Wachtel E, Roughley P (2014) Structure, function, aging and turnover of aggrecan in the intervertebral disc. Biochim Biophys Acta 1840(10):3181–3189

    Article  CAS  PubMed  Google Scholar 

  8. Freemont AJ (2009) The cellular pathobiology of the degenerate intervertebral disc and discogenic back pain. Rheumatology (Oxford) 48(1):5–10

    Article  CAS  Google Scholar 

  9. Phillips KL, Jordan-Mahy N, Nicklin MJ, Le Maitre CL (2013) Interleukin-1 receptor antagonist deficient mice provide insights into pathogenesis of human intervertebral disc degeneration. Ann Rheum Dis 72(11):1860–1867

    Article  CAS  PubMed  Google Scholar 

  10. Ellman MB, Kim JS, An HS, Chen D, KC R, An J, Dittakavi T, van Wijnen AJ, Cs-Szabo G, Li X, Xiao G, An S, Kim SG, Im HJ (2012) Toll-like receptor adaptor signaling molecule MyD88 on intervertebral disk homeostasis: in vitro, ex vivo studies. Gene 505(2):283–290

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Wang M, Tang D, Shu B, Wang B, Jin H, Hao S, Dresser KA, Shen J, Im HJ, Sampson ER, Rubery PT, Zuscik MJ, Schwarz EM, O’Keefe RJ, Wang Y, Chen D (2012) Conditional activation of β-catenin signaling in mice leads to severe defects in intervertebral disc tissue. Arthritis Rheum 64(8):2611–2623

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Di Martino A, Vaccaro AR, Yung Lee J, Denaro V, Lim MR (2005) Nucleus pulposus replacement: basic science and indications for clinical use. Spine 30(16 Suppl):S16–S22

    Article  PubMed  Google Scholar 

  13. Di Martino A, Merlini L, Faldini C (2013) Autoimmunity in intervertebral disc herniation: from bench to bedside. Expert Opin Ther Targets 17(12):1461–1470

    Article  PubMed  Google Scholar 

  14. Hegewald AA, Ringe J, Sittinger M et al (2008) Regenerative treatment strategies in spinal surgery. Front Biosci 13:1507–1525

    Article  CAS  PubMed  Google Scholar 

  15. Gou S, Oxentenko SC, Eldrige JS, Xiao L, Pingree MJ, Wang Z, Perez-Terzic C, Qu W (2014) Stem cell therapy for intervertebral disk regeneration. Am J Phys Med Rehabil 93(11 Suppl 3):S122–S131

    Article  PubMed  Google Scholar 

  16. Sun Z, Luo B, Liu ZH, Samartzis D, Liu Z, Gao B, Huang L, Luo ZJ (2015) Adipose-derived stromal cells protect intervertebral disc cells in compression: implications for stem cell regenerative disc therapy. Int J Biol Sci 11(2):133–143

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  17. Gantenbein B, Calandriello E, Wuertz-Kozak K, Benneker LM, Keel MJ, Chan SC (2014) Activation of intervertebral disc cells by co-culture with notochordal cells, conditioned medium and hypoxia. BMC Musculoskelet Disord 15:422

    Article  PubMed Central  PubMed  Google Scholar 

  18. Masuda K (2008) Biological repair of the degenerated intervertebral disc by the injection of growth factors. Eur Spine J 17(Suppl 4):441–451

  19. Tolonen J, Grönblad M, Vanharanta H et al (2006) Growth factor expression in degenerated intervertebral disc tissue. An immunohistochemical analysis of transforming growth factor beta, fibroblast growth factor and platelet-derived growth factor. Eur Spine J 15:588–596

    Article  PubMed Central  PubMed  Google Scholar 

  20. Thompson JP, Oegema TR Jr, Bradford DS (1991) Stimulation of mature canine intervertebral disc by growth factors. Spine 16:253–260

    Article  CAS  PubMed  Google Scholar 

  21. Risbud MV, Di Martino A, Guttapalli A, Seghatoleslami R, Denaro V, Vaccaro AR, Albert TJ, Shapiro IM (2006) Towards an optimum system for intervertebral disc organ culture: TGF-b3 enhances nucleus pulposus and annulus fibrosus survival and function through modulation of TGFb-R expression and ERK signaling. Spine 31(8):884–890

  22. Chujo T, An HS, Akeda K et al (2006) Effects of growth differentiation factor-5 on the intervertebral disc–in vitro bovine study and in vivo rabbit disc degeneration model study. Spine 31:2909–2917

    Article  PubMed  Google Scholar 

  23. Tolonen J, Grönblad M, Vanharanta H et al (2006) Growth factor expression in degenerated intervertebral disc tissue. An immunohistochemical analysis of transforming growth factor beta, fibroblast growth factor and platelet-derived growth factor. Eur Spine J 15:588–596

    Article  PubMed Central  PubMed  Google Scholar 

  24. Vadalà G, Russo F, Di Martino A, Denaro V (2015) Intervertebral disc regeneration: from the degenerative cascade to molecular therapy and tissue engineering. J Tissue Eng Regen Med 9(6):679–690

    Article  PubMed  Google Scholar 

  25. Lucarelli E, Beccheroni A, Donati D, Sangiorgi L, Cenacchi A, Del Vento AM, Meotti C, Bertoja AZ, Giardino R, Fornasari PM, Mercuri M, Picci P (2003) Platelet-derived growth factors enhance proliferation of human stromal stem cells. Biomaterials 24(18):3095–3100

    Article  CAS  PubMed  Google Scholar 

  26. Sánchez AR, Sheridan PJ, Kupp LI (2003) Is platelet-rich plasma the perfect enhancement factor? A current review. Int J Oral Maxillofac Implants 18:93–103

    PubMed  Google Scholar 

  27. Kon E, Filardo G, Di Martino A et al (2011) Platelet-rich plasma (PRP) to treat sports injuries: evidence to support its use. Knee Surg Sports Traumatol Arthrosc 19:516–527

    Article  PubMed  Google Scholar 

  28. Andia I, Sánchez M, Maffulli N (2011) Platelet rich plasma therapies for sports muscle injuries: any evidence behind clinical practice? Expert Opin Biol Ther 11:509–518

    Article  PubMed  Google Scholar 

  29. Kon E, Mandelbaum B, Buda R et al (2011) Platelet-rich plasma intraarticular injection versus hyaluronicacid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy 27(11):1490–1501

    Article  PubMed  Google Scholar 

  30. Sánchez M, Guadilla J, Fiz N, Andia I (2012). Ultrasound-guided platelet rich plasma injections for the treatment of osteoarthritis of the hip. Rheumatology (Oxford) 51(1):144

  31. Bernuzzi G, Petraglia F, Pedrini MF et al (2014) Use of platelet-rich plasma in the care of sports injuries: our experience with ultrasound-guided injection. Blood Transfus 12(Suppl 1):s229–s234

    PubMed Central  PubMed  Google Scholar 

  32. Kepler CK, Anderson DG, Tannoury C, Ponnappan RK (2011) Intervertebral disk degeneration and emerging biologic treatments. J Am Acad Orthop Surg 19(9):543–553

  33. Akeda K, An HS, Pichika R, Attawia M, Thonar EJ, Lenz ME, Uchida A, Masuda K (2006) Platelet-rich plasma (PRP) stimulates the extracellular matrix metabolism of porcine nucleus pulposus and anulus fibrosus cells cultured in alginate beads. Spine (Phila Pa 1976) 31(9):959–66

  34. Mietsch A, Neidlinger-Wilke C, Schrezenmeier H, Mauer UM, Friemert B, Wilke HJ, Ignatius A (2013) Evaluation of platelet-rich plasma and hydrostatic pressure regarding cell differentiation in nucleus pulposus tissue engineering. J Tissue Eng Regen Med 7(3):244–252

    Article  CAS  PubMed  Google Scholar 

  35. Liu MC, Chen WH, Wu LC, Hsu WC, Lo WC, Yeh SD, Wang MF, Zeng R, Deng WP (2014) Establishment of a promising human nucleus pulposus cell line for intervertebral disc tissue engineering. Tissue Eng Part C Methods 20(1):1–10

    Article  PubMed  Google Scholar 

  36. Pirvu TN, Schroeder JE, Peroglio M, Verrier S, Kaplan L, Richards RG, Alini M, Grad S (2014) Platelet-rich plasma induces annulus fibrosus cell proliferation and matrix production. Eur Spine J 23(4):745–753

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  37. Chen WH, Lo WC, Lee JJ, Su CH, Lin CT, Liu HY, Lin TW, Lin WC, Huang TY, Deng WP (2006) Tissue-engineered intervertebral disc and chondrogenesis using human nucleus pulposus regulated through TGF-beta1 in platelet-rich plasma. J Cell Physiol 3:744–754

    Article  Google Scholar 

  38. Kim HJ, Yeom JS, Koh YG, Yeo JE, Kang KT, Kang YM, Chang BS, Lee CK (2014) Anti-inflammatory effect of platelet-rich plasma on nucleus pulposus cells with response of TNF-α and IL-1J Orthop Res 32(4): 551–556

  39. Nagae M, Ikeda T, Mikami Y, Hase H, Ozawa H, Matsuda K, Sakamoto H, Tabata Y, Kawata M, Kubo T (2007) Intervertebral disc regeneration using platelet-rich plasma and biodegradable gelatin hydrogel microspheres. Tissue Eng 13(1):147–158

    Article  CAS  PubMed  Google Scholar 

  40. Sawamura K, Ikeda T, Nagae M, Okamoto S, Mikami Y, Hase H, Ikoma K, Yamada T, Sakamoto H, Matsuda K, Tabata Y, Kawata M, Kubo T (2009) Characterization of in vivo effects of platelet-rich plasma and biodegradable gelatin hydrogel microspheres on degenerated intervertebral discs. Tissue Eng Part A 15(12):3719–3727

    Article  CAS  PubMed  Google Scholar 

  41. Obata S, Akeda K, Imanishi T, Masuda K, Bae W, Morimoto R, Asanuma Y, Kasai Y, Uchida A, Sudo A (2012) Effect of autologous platelet-rich plasma-releasate on intervertebral disc degeneration in the rabbit anular puncture model: a preclinical study. Arthritis Res Ther. 14(6):R241

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  42. Hu X, Wang C, Rui Y, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi (2012) An experimental study on effect of autologous platelet-rich plasma on treatment of early intervertebral disc degeneration 26(8):977–983 (Chinese)

  43. Gullung GB, Woodall JW, Tucci MA, James J, Black DA, McGuire RA (2011) Platelet-rich plasma effects on degenerative disc disease: analysis of histology and imaging in an animal model. Evid Based Spine Care J. 2(4):13–18

    Article  PubMed Central  PubMed  Google Scholar 

  44. Chen WH, Liu HY, Lo WC, Wu SC, Chi CH, Chang HY, Hsiao SH, Wu CH, Chiu WT, Chen BJ, Deng WP (2009) Intervertebral disc regeneration in an ex vivo culture system using mesenchymal stem cells and platelet-rich plasma. Biomaterials 30(29):5523–5533

    Article  CAS  PubMed  Google Scholar 

  45. Johnson WE, Eisenstein SM, Roberts S (2001) Cell cluster formation in degenerate lumbar intervertebral discs is associated with increased disc cell proliferation. Connect Tissue Res 42:197–207

    Article  CAS  PubMed  Google Scholar 

  46. Roberts S, Caterson B, Menage J, Evans EH, Jaffray DC, Eisenstein SM (2000) Matrix metalloproteinases and aggrecanase: their role in disorders of the human intervertebral disc. Spine 25:3005–3013

    Article  CAS  PubMed  Google Scholar 

  47. Oegema TR Jr, Johnson SL, Aguiar DJ, Ogilvie JW (2000) Fibronectin and its fragments increase with degeneration in the human intervertebral disc. Spine 25:2742–2747

    Article  PubMed  Google Scholar 

  48. Formica M, Berjano P, Cavagnaro L, Zanirato A, Piazzolla A, Formica C (2014) Extreme lateral approach to the spine in degenerative and post traumatic lumbar diseases: selection process, results and complications. Eur Spine J 23(Suppl 6):684–692

  49. Allain J, Delecrin J, Beaurain J, Poignard A, Vila T, Flouzat-Lachaniette CH (2014) Stand-alone ALIF with integrated intracorporeal anchoring plates in the treatment of degenerative lumbar disc disease: a prospective study on 65 cases. Eur Spine J 23(10):2136–2143

    Article  PubMed  Google Scholar 

  50. Høy K, Bünger C, Niederman B, Helmig P, Hansen ES, Li H, Andersen T (2013) Transforaminal lumbar interbody fusion (TLIF) versus posterolateral instrumented fusion (PLF) in degenerative lumbar disorders: a randomized clinical trial with 2-year follow-up. Eur Spine J 22(9):2022–2029

    Article  PubMed Central  PubMed  Google Scholar 

  51. Cavagnaro L, Basso M, Alessio Mazzola M, Formica M (2014) Lumbar traction in the management of low back pain: a survey of latest results. J Nov Physiother 4:5

    Article  Google Scholar 

  52. Wegner I, Widyahening IS, van Tulder MW, Blomberg SE, de Vet HC (2013) Traction for low-back pain with or without sciatica. Cochrane Database Syst Rev 8:CD003010

  53. Anderson DG, Albert TJ, Fraser JK, Risbud M, Wuisman P, Meisel HJ, Tannoury C, Shapiro I, Vaccaro AR (2005) Cellular therapy for disc degeneration. Spine 30:S14–S19

    Article  PubMed  Google Scholar 

  54. Alini M, Roughley PJ, Antoniou J, Stoll T, Aebi M (2002) A biological approach to treating disc degeneration: not for today, but may be for tomorrow. Eur Spine J 11:S215–S220

    PubMed Central  PubMed  Google Scholar 

  55. Crevensten G, Walsh AJ, Ananthakrishnan D, Page P, Wahba GM, Lotz JC, Berven S (2004) Intervertebral disc cell therapy for regeneration: mesenchymal stem cell implantation in rat intervertebral discs. Ann Biomed Eng 32:430–434

    Article  PubMed  Google Scholar 

  56. Fontana G, See E, Pandit A (2015) Current trends in biologics delivery to restore intervertebral disc anabolism. Adv Drug Deliv Rev 84:146–158

  57. Carter CA, Jolly DG, Worden CE Sr, Hendren DG, Kane CJ (2003) Platelet-rich plasma gel promotes differentiation and regeneration during equine wound healing. Exp Mol Pathol 74(3):244–255

    Article  CAS  PubMed  Google Scholar 

  58. Weibrich G, Hansen T, Kleis W et al (2004) Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration. Bone 34:665–671

    Article  CAS  PubMed  Google Scholar 

  59. Marx RE (2001) Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent 10:225–228

    Article  CAS  PubMed  Google Scholar 

  60. Castillo TN, Pouliot MA, Kim HJ et al (2011) Comparison of growth factor and platelet concentration from commercial platelet-rich plasma separation systems. Am J Sports Med 39:266–271

    Article  PubMed  Google Scholar 

  61. Orozco L, Soler R, Morera C, Alberca M, Sánchez A, García-Sancho J (2011) Intervertebral disc repair by autologous mesenchymal bone marrow cells: a pilot study. Transplantation 92(7):822–828

  62. Akeda K, Imanishi T, Ohishi K, Masuda K, Uchida A, Sakakibara T, Kasai Y, Sudo A (2012) intradiscal injection of autologous platelet-rich-plasma for the treatment of lumbar disc degeneration preliminary prospective clinical trial for discogenic low back pain patients. Poster No. 2194. ORS 2012 Annual Meeting

  63. Wang SZ, Rui YF, Tan Q et al (2013) Enhancing intervertebral disc repair and regeneration through biology: platelet-rich plasma as an alternative strategy. Arthritis Res Ther 15:220

    Article  PubMed Central  PubMed  Google Scholar 

  64. Wang SZ, Chang Q, Lu J, Wang C (2015) Growth factors and platelet-rich plasma: promising biological strategies for early intervertebral disc degeneration. Int Orthop

  65. Landis SC et al (2012) A call for transparent reporting to optimize the predictive value of preclinical research. Nature 490(7419):187–191

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We gratefully acknowledge Prof. Roberta Aronica for English revision of the current manuscript.

Author information

Authors and Affiliations

  1. Clinica Ortopedica, University of Genoa, IRCCS AOU San Martino-IST, Istituto Nazionale per la Ricerca sul Cancro, Largo Rosanna Benzi, 10 16132, Genoa, Italy

    Matteo Formica, Luca Cavagnaro & Marco Basso

  2. CVCO, IRCCS Istituto Ortopedico Galeazzi, Via Riccardo Galeazzi 420161, Milan, Italy

    Carlo Formica

  3. CBA, Advanced Biotechnology Center, Largo R. Benzi 10, 16132, Genoa, Italy

    Milena Mastrogiacomo

  4. Department of Orthopaedics and Trauma Surgery, University Campus Bio-Medico of Rome, Via Álvaro del Portillo 21, Rome, Italy

    Alberto Di Martino

Authors
  1. Matteo Formica
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luca Cavagnaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Carlo Formica
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Milena Mastrogiacomo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Marco Basso
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Alberto Di Martino
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matteo Formica.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Formica, M., Cavagnaro, L., Formica, C. et al. What is the preclinical evidence on platelet rich plasma and intervertebral disc degeneration?. Eur Spine J 24, 2377–2386 (2015). https://doi.org/10.1007/s00586-015-4189-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00586-015-4189-2

Keywords

Search

Navigation